Pages that link to "Q78852509"
Jump to navigation
Jump to search
The following pages link to Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours (Q78852509):
Displaying 34 items.
- BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status (Q21245742) (← links)
- Clinical significance of mismatch repair gene expression in sporadic colorectal cancer (Q34292357) (← links)
- Immunohistochemical analysis of mismatch repair proteins in Iranian colorectal cancer patients at risk for lynch syndrome (Q35179173) (← links)
- Mismatch repair genes expression defects & association with clinicopathological characteristics in colorectal carcinoma (Q35234577) (← links)
- Cost effectiveness of a new strategy to identify HNPCC patients (Q35597163) (← links)
- Identification of Cancer Patients with Lynch Syndrome: Clinically Significant Discordances and Problems in Tissue-Based Mismatch Repair Testing (Q35740291) (← links)
- The utility of immunohistochemical detection of DNA mismatch repair gene proteins. (Q35904483) (← links)
- Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer (Q35988113) (← links)
- Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome (Q36246500) (← links)
- Microsatellite instability in gastrointestinal tract cancers: a brief update (Q36338134) (← links)
- Human mutL homolog 1 expression characteristic and prognostic effect on patients with sporadic colorectal cancer (Q36412420) (← links)
- Mismatch repair hMSH2, hMLH1, hMSH6 and hPMS2 mRNA expression profiles in precancerous and cancerous urothelium (Q36475458) (← links)
- Accuracy of MSI testing in predicting germline mutations of MSH2 and MLH1: a case study in Bayesian meta-analysis of diagnostic tests without a gold standard (Q36507457) (← links)
- A unique MSH2 exon 8 deletion accounts for a major portion of all mismatch repair gene mutations in Lynch syndrome families of Sardinian origin (Q36543031) (← links)
- DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer (Q36613849) (← links)
- High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis (Q36683862) (← links)
- Detection of hMSH2 and hMLH1 mutations in Chinese hereditary non-polyposis colorectal cancer kindreds (Q37174196) (← links)
- Low expression of MSH2 DNA repair protein is associated with poor prognosis in head and neck squamous cell carcinoma (Q37437757) (← links)
- Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review (Q37798758) (← links)
- Lynch syndrome: clinical, pathological, and genetic insights (Q37987828) (← links)
- Colorectal cancer prognosis depends on T-cell infiltration and molecular characteristics of the tumor (Q38412549) (← links)
- Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature (Q41343102) (← links)
- Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group (Q43894713) (← links)
- Association of DNA repair genes polymorphisms and mutations with increased risk of head and neck cancer: a review. (Q47104433) (← links)
- Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis (Q51137586) (← links)
- A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns. (Q54210037) (← links)
- Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer. (Q54456628) (← links)
- Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. (Q54661743) (← links)
- Carcinomes urothéliaux de la voie excrétrice supérieure (Q57565244) (← links)
- The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer (Q57741867) (← links)
- Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? (Q57741879) (← links)
- Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient (Q64109038) (← links)
- The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer (Q81637142) (← links)
- Clinical significance of MLH1/MSH2 for stage II/III sporadic colorectal cancer (Q91672149) (← links)